Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Awards highlight Avantor's commitment to the Biopharma industry
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Bloom has pioneered a technology to transform plant waste into valuable chemical products
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Subscribe To Our Newsletter & Stay Updated
